0B68 Jabbour, Serge - Thomas Jefferson University - Thomas Jefferson University
saj102

Serge A. Jabbour, DM, FACP, FACE

Contact Dr. Jabbour

Walnut Towers
211 S. Ninth Street, Suite 600
Philadelphia, PA 19107

(215) 955-1925
(215) 928-3160 fax

Most Recent Peer-reviewed Publications

  1. Dapagliflozin is effective as add-on therapy to sitagliptin with or withoutmetformin: A 24-Week, multicenter, randomized, double-blind, placebo-controlled study
  2. SGLT2 inhibitors to control glycemia in type 2 diabetes mellitus: a new approach to an old problem.
  3. Collaboration designed to increase translation of diabetes research outcomes into clinical practice
  4. Targeting renal glucose reabsorption for the treatment of type 2 diabetes mellitus using the SGLT2 inhibitor Dapagliflozin
  5. Subclinical hyperthyroidism: Current concepts and scintigraphic imaging
  6. Exenatide once weekly in type 2 diabetes mellitus
  7. Sodium Glucose Cotransporter 2 Inhibitors
  8. Management of diabetes mellitus in the elderly
  9. 46, XX SRY-positive male syndrome presenting with primary hypogonadism in the setting of scleroderma
  10. Advantages of extended-release metformin in patients with type 2 diabetes mellitus
  11. Skin manifestations of hormone-secreting tumors
  12. The importance of reducing hyperglycemia while preserving insulin secretion-the rationale for sodium-coupled glucose co-transporter 2 inhibition in diabetes
  13. Visual vignette.
  14. Editorial: Type 2 diabetes and HbA1c goal: Time for individualised therapy
  15. Perioperative Management of Endocrine Disorders
  16. A comparison of glycaemic variability in CSII vs. MDI treated type 1 diabetic patients using CGMS
  17. Endocrine incidentalomas
  18. Sodium glucose co-transporter 2 inhibitors: Blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes
  19. Primary care physicians and insulin initiation: Multiple barriers, lack of knowledge or both?
  20. Accuracy of bedside capillary blood glucose measurements in critically ill patients
0